Related references
Note: Only part of the references are listed.Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells
J. Joseph Melenhorst et al.
NATURE (2022)
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Amelie Cachot et al.
SCIENCE ADVANCES (2021)
Epstein-Barr Virus plus B Cells in Breast Cancer Immune Response: A Case Report
Andrea Aran et al.
FRONTIERS IN IMMUNOLOGY (2021)
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
David Y. Oh et al.
CELL (2020)
Mechanism of EBV inducing anti-tumour immunity and its therapeutic use
Il-Kyu Choi et al.
NATURE (2020)
The Global Landscape of EBV-Associated Tumors
Claire Shannon-Lowe et al.
FRONTIERS IN ONCOLOGY (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses
Il-Kyu Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Epstein–Barr Virus and Cancer
Paul J. Farrell
Annual Review of Pathology-Mechanisms of Disease (2018)
Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection
Kazushi Izawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Epstein-Barr Virus LMP1-Mediated Oncogenicity
Liang Wei Wang et al.
JOURNAL OF VIROLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Epstein-Barr virus: more than 50 years old and still providing surprises
Lawrence S. Young et al.
NATURE REVIEWS CANCER (2016)
The immunology of Epstein-Barr Virus Induced Disease
Graham S. Taylor et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events
Samantha K. Dunmire et al.
PLOS PATHOGENS (2015)
Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children
Shamanthi Jayasooriya et al.
PLOS PATHOGENS (2015)
Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors
Gennadiy Bondarenko et al.
NEOPLASIA (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
Epstein-barr virus vaccines
Jeffrey I. Cohen
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Virus and Autoantigen-Specific CD4+T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
Stefanie Linnerbauer et al.
PLOS PATHOGENS (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition
Henry H. Balfour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Shigehisa Kitano et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
Baochun Zhang et al.
CELL (2012)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Characterization of Lymphomas Developing in Immunodeficient Mice Implanted With Primary Human Non-Small Cell Lung Cancer
Thomas John et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
Heather M. Long et al.
JOURNAL OF IMMUNOLOGY (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus
Bernhard Ehlers et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
Chrystal U. Louis et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation
Corey Smith et al.
BLOOD (2009)
CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells
Heather M. Long et al.
BLOOD (2009)
Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition
Jill M. Brooks et al.
JOURNAL OF IMMUNOLOGY (2009)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
The AP1-dependent secretion of galectin-1 by Reed - Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children
Ann M. Moormann et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
KCM Straathof et al.
BLOOD (2005)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
High physiological levels of LMP1 result in phosphorylation of eIF2α in Epstein-Barr virus-infected cells
N Lam et al.
JOURNAL OF VIROLOGY (2004)
Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease
CM Bollard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
B cells under influence:: Transformation of B cells by Epstein-Barr virus
R Küppers
NATURE REVIEWS IMMUNOLOGY (2003)
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells
A Moosmann et al.
BLOOD (2002)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors
AD Wilson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells
A Khanolkar et al.
VIROLOGY (2001)
Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype
MK Maini et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
